RDInvesting wrote that biotechnology stocks were poised to soar in 2017 and noted that MYOS RENS Technology Inc. (Nasdaq: MYOS) had recently spiked. Shares of the bionutrition and biotherapeutics company soared $1.11 to close at $4.72.
MYOS REN poised to soar
February 07, 2017 at 16:40 PM EST
